Series B - OpenEvidence
Investment Firm
Overview
OpenEvidence is a common problem in many high-value domains. It's a huge challenge in medicine.
Announced Date
Jul 01, 2022
Funding Type
Series B
Highlights
Location
United States, North America
Social
Investor Lead
N/A
Participant Investors
3
| Investor Name |
|---|
 Jim Breyer |
 Ken Moelis |
Round Details and Background
OpenEvidence raised $27000000 on 2022-07-01 in Series B
OpenEvidence is a common problem in many high-value domains. It's a huge challenge in medicine.
Company Funding History
2
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Nov 01, 2021 |  Seed Round - OpenEvidence | 1 | - | 5.0M |
| Jul 01, 2022 | Series B - OpenEvidence | 3 | - | 27.0M |
Recent Activity
There is no recent news or activity for this profile.